Untitled

The global pharmaceutical landscape is moving faster than ever. For drug developers and manufacturers, success is no longer just about discovering or producing a great molecule—it is about getting it to the right markets at the exact right time.

Navigating complex regulatory frameworks, managing high R&D costs, and scaling commercial distribution globally can stretch even the most robust organizations. This is where strategic in-licensing and out-licensing become essential engines for sustainable growth.

At Neunco, we bridge the gap between innovation and commercial reality. Our specialized licensing services are designed to help pharmaceutical companies expand their global footprints, optimize their product portfolios, and maximize revenue potential.

The Strategic Power of In-Licensing vs. Out-Licensing

Whether you are looking to fill gaps in your current pipeline or monetize an asset you’ve already developed, a structured licensing strategy keeps you agile.

1. In-Licensing: Accelerating Portfolio Growth

Developing a new drug from scratch takes years and costs millions. In-licensing allows companies to acquire the rights to developed or late-stage molecules, advanced formulations, or approved products.

Speed to Market: Skip early-stage development hurdles and introduce commercial-ready products to your portfolio.

Risk Mitigation: By licensing products with proven clinical data or existing regulatory approvals, you drastically lower R&D risk.

Strategic Alignment: Quickly expand into new therapeutic areas without building new research infrastructure from scratch.

2. Out-Licensing: Unleashing Asset Potential

If your team has developed a valuable asset but lacks the infrastructure, local footprint, or capital to commercialize it globally, out-licensing is the ideal path forward.

Immediate Monetization: Secure upfront payments, milestone rewards, and ongoing royalty streams to reinvest in your core pipeline.

Global Footprint, Local Expertise: Partner with established regional players who understand local market access, pricing dynamics, and distribution networks.

Resource Optimization: Focus your capital and commercial teams on your primary therapeutic areas while partners drive value from your secondary assets.

Why Partner with Neunco for Licensing Services?

Finding a molecule or a buyer is the easy part. The real challenge lies in finding the right match, verifying asset integrity, and structuring a deal that protects your long-term commercial interests.

Neunco brings deep domain expertise and a reliable network to streamline the entire lifecycle of pharmaceutical licensing:

Robust Global Network: We connect innovators with commercial powerhouses across key global markets, matching the right asset with the right partner infrastructure.

End-to-End Deal Facilitation: From initial scouting and technical due diligence to final contract negotiation, we ensure compliance, transparency, and strategic alignment at every step.

Regulatory & Commercial Intelligence: Our team evaluates assets not just on scientific merit, but on market viability, competitive landscapes, and regulatory feasibility to guarantee a strong return on investment (ROI).

Streamline Your Next Move

In a highly competitive market, the right licensing agreement can transform your business trajectory overnight. Whether you want to diversify your current product offerings or take your proprietary assets global, Neunco has the commercial insight and operational expertise to make it happen.

 For decades, the standard playbook for drug development followed a predictable, linear path: a pharmaceutical company discovered a molecule, built a highly specialized factory, and manufactured the drug at scale.

Today, that linear model is broken. The skyrocketing complexity of modern therapeutics—ranging from high-potency active pharmaceutical ingredients (APIs) for targeted oncology to diverse advanced dosage forms—means that owning an isolated production facility is no longer practical or cost-effective. Instead, modern pharmaceutical success relies on building an entire collaborative ecosystem.

Within this shift, finding the right manufacturing partner has become a monumental hurdle. This is where Neunco enters the picture. Operating as a premier global pharmaceutical consultancy and strategic contract services provider, Neunco acts as the crucial architect connecting pharmaceutical brands with world-class, pre-validated manufacturing networks.

Moving Beyond a "Vendor" Mentality to Networked Innovation

In the current landscape, a Contract Manufacturing Organization (CMO) or Contract Development and Manufacturing Organization (CDMO) cannot just be a transactional vendor. They must be an integrated strategic partner.

Because navigating thousands of global suppliers is a massive drain on capital and time, Neunco simplifies the entire journey. Leveraging a massive, deeply vetted global database, Neunco matches generic and innovative pharmaceutical companies with the exact CRO, CMO, or CDMO needed for their specific drug profile.

Neunco’s tailored curation process eliminates guesswork, ensuring your project lands with a partner who ticks every critical operational box:

Platform-First Scaling: The partners within Neunco’s network offer pre-validated processes. Whether you need a small-batch pilot run, a complete site transfer, or end-to-end commercial batch production, the onboarding is seamless.

Agnostic Formulation Capabilities: Through Neunco, companies can access manufacturing for complex, high-potency drugs across highly specific dosage forms—including injectables (vials, ampoules, lyophilized, and pre-filled syringes), inhalers, patches, advanced orals, films, and aerosols.

Cutting-Edge Technology: Neunco bridges the gap to advanced production methods, including continuous manufacturing technologies that operate 24/7 to boost consistency, eliminate batch-type waste, and drastically improve time-to-market.

Navigating the Quality, Regulatory, and ESG Landscape

In pharmaceutical manufacturing, regulatory compliance is the ultimate gatekeeper. A single misstep can delay a launch by years or trigger catastrophic recalls.

Neunco actively mitigates this risk by selecting manufacturing partners who operate on a strict Quality by Design (QbD) principle and feature a meticulous, dossier-oriented approach to support flawless regulatory filing.

Global Standards Guaranteed: Every manufacturing partner recommended by Neunco maintains strict Good Manufacturing Practice (GMP) compliance. Furthermore, Neunco's primary distribution nodes—including its Netherlands hub and its United States facility—hold elite EU-GDP and USA-WDA certifications.

Beyond baseline compliance, the landscape demands sustainable operations. Neunco actively factors Environmental, Social, and Governance (ESG) criteria into its curation process, ensuring partners are evaluated on their carbon footprint, chemical waste management, and water usage to match modern corporate responsibility goals.

Accelerate Your Journey with Confidence

Timing is everything. Partnering with the wrong contract manufacturer can compromise years of research and cost millions in capital expenditure.

Neunco removes the uncertainty from the equation. By blending market intelligence, an expansive international network, and absolute project accountability, Neunco transforms your drug blueprint into a market-ready breakthrough.

Instead of navigating the complex global supply web entirely on your own, you can leverage Neunco’s deep institutional expertise to scale up your production safely, efficiently, and profitably.

 The pharmaceutical landscape moves fast. Between navigating complex regulatory frameworks, managing fluctuating raw material costs, and racing to bring a drug to market, pharmaceutical companies face a mountain of operational challenges. One critical bottleneck is the production of the core element of any drug product: the Active Pharmaceutical Ingredient (API).

Because building and maintaining specialized, compliant in-house API manufacturing facilities requires massive capital expenditure, strategic outsourcing has evolved from an occasional cost-saving tactic into a fundamental growth strategy.

But finding, auditing, and managing the right manufacturing partner is a complex undertaking. That is where a specialized pharmaceutical consultancy like Neunco bridges the gap. By leveraging a deep database and global network, Neunco connects pharma companies with international-standard Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs).

What is API Contract Manufacturing?

An Active Pharmaceutical Ingredient (API) is the biologically active component of a drug product (whether it is a tablet, capsule, cream, or injectable) that produces the intended health effect.

API Contract Manufacturing is the strategic outsourcing of this chemical or biological synthesis process to a specialized third-party manufacturer. Instead of handling the labor-intensive, highly regulated manufacturing steps in-house, pharmaceutical brands partner with dedicated contract companies equipped to scale production efficiently.

The Core Advantages of Outsourcing API Production

Partnering with an API contract manufacturer offers distinct operational and financial advantages that can reshape a pharmaceutical company's bottom line.

1. Significant Reduction in Capital Expenditure (CapEx)

Building a fully compliant, state-of-the-art API manufacturing site requires an enormous upfront investment in specialized equipment, technology upgrades, and robust compliance infrastructure. Outsourcing eliminates these overhead costs entirely, allowing companies to redirect vital capital toward early-stage research and development (R&D) or commercial marketing efforts.

2. Economies of Scale & Optimized Costs

Specialized pharma contract companies frequently serve multiple clients, allowing them to achieve economies of scale that are difficult for a single brand to match. Raw material procurement, high-volume logistics, and process optimizations mean lower per-unit manufacturing costs. Furthermore, utilizing an established partner minimizes local labor training costs without compromising on end-product quality.

3. Accelerated Time-to-Market

Speed is a massive competitive advantage in the pharma ecosystem. Contract manufacturers already have validated processes, trained personnel, and ready-to-use facilities in place. This operational readiness slashes the time required to scale up a molecule from lab-scale synthesis to commercial-scale production.

4. Navigating Global Capacity & Innovation

The industry is seeing highly distinct global patterns, including a surge in complex APIs, a massive rise in generic drug production, and a push toward "green chemistry" and sustainability. Top-tier contract partners are frequently at the forefront of these innovations, implementing advanced tech like AI-driven process optimization and automated batch processing to minimize side reactions and maximize yield.

How Neunco Streamlines the Contract Manufacturing Process

The biggest challenge in contract manufacturing isn't understanding the benefits—it’s finding a partner who checks every single box. Every drug is unique, and every market has its own strict compliance barriers.

At Neunco, we eliminate the friction of partner selection. Acting as a strategic consultative bridge, our team conducts exhaustive research and background vetting to map your specific drug profile, target markets, and volume requirements to the ideal CMO or CDMO.

With distribution channels and strategic infrastructure rooted in the US, Europe (including our EU-GDP certified warehouse in the Netherlands), and India, Neunco ensures that your strategic sourcing, clinical trial supplies, and API contract manufacturing align perfectly to protect your margins, secure your intellectual property, and accelerate your global reach.

The global pharmaceutical landscape is moving faster than ever. For generic drug developers and clinical trial sponsors, bringing an affordable, life-saving therapy to market hinges on one critical, foundational element: Reference Listed Drug (RLD) and Comparator sourcing.

India has firmly established itself as the "pharmacy of the world," standing as a massive hub for generic formulation development and clinical research. However, navigating the intricate regulations, strict timeline dependencies, and delicate logistics of RLD sourcing in India presents a unique set of challenges.

A single delay in obtaining the exact batch of an RLD can stall a bioequivalence (BE) study, blowing out budgets and delaying market entry. That is where strategic supply chain orchestration becomes a necessity. Here is a look at what it takes to master RLD sourcing in India—and how Neunco streamlines the entire process from origin to destination.

The Real-World Obstacles in RLD and Comparator Sourcing

Sourcing a Reference Listed Drug or a clinical trial comparator is rarely as simple as placing an order. Drug developers frequently hit major bottlenecks that threaten their study timelines:

Strict Sourcing Criteria: Generic development often requires RLDs from a highly specific country of origin, single vs. multiple batch lots, specific batch numbers, or exceptionally long expiration dates to cover the entire life cycle of a study.

Logistical Fragility: Modern therapeutics—especially biologics and advanced small molecules—require unbroken cold chain infrastructure. A minor temperature excursion can compromise millions of dollars of product.

Fragmented Supply Chains: Dealing with multiple vendors across different regions often leads to opaque tracking, unpredictable delivery times, and heightened regulatory compliance risks.

To mitigate these risks, pharmaceutical manufacturers need more than a broker; they need a partner with a transparent, fully validated global footprint.

The Neunco Advantage: Seamless Execution from India to the World

Partnering with Neunco for your Indian and global RLD requirements provides distinct operational advantages that keep your projects on track:

1. True Customer-Centric Customization

We don't believe in one-size-fits-all sourcing. We cater to precise, highly demanding standard needs, including:

Sourcing directly from specific targeted countries.

Providing "one-to-many" pack deliveries.

Securing specific batch numbers or single/multi-batch lots.

Guaranteeing long expiry dates to safeguard extended clinical studies.

2. Fully Certified, State-of-the-Art Global Storage

Clinical Trial Supply Management (CTSM) relies heavily on secure, compliant storage to mitigate inventory risk. Neunco boasts an impressive global network, including an EU GDP-certified warehouse in the Netherlands and a certified licensed distribution center in New Jersey, USA.

With a combined capacity of over 20,000+ pallet positions across ambient, refrigerated, and frozen conditions, we can securely house your RLD and comparator requirements over the entire lifecycle of your study.

3. Unbroken, Validated Global Distribution

Holding a Wholesaler Distribution Authorization (WDA) license, Neunco coordinates seamlessly across India, South East Asia, the USA, Europe, Canada, Australia, Japan, Korea, and Latin America. We partner exclusively with qualified logistics experts to operate temperature-controlled specialized vehicles, ensuring robust cold-chain integrity right down to the last-mile delivery.

4. Radical Supply Chain Transparency

No more guessing where your critical trial supplies are. Neunco operates with absolute openness, extending our internal status tracking system directly to our clients. You can actively monitor the milestones of your order cycle in real-time.

Accelerate Your Development Journey

The success of a clinical trial or a generic drug development program depends on a traceable, structured, and resilient supply chain. Neunco pairs deep market expertise with a powerful research and project management team to act as your ideal cost-management and sourcing partner.

Don't let sourcing bottlenecks stall your next breakthrough. Connect with the Neunco team today to secure your strategic RLD and comparator supply, on time and in full.

Developing a generic drug is a race against time, regulatory hurdles, and market competition. At the heart of this high-stakes process is a single, foundational element: the Reference Listed Drug (RLD) — the brand-name drug approved by regulatory bodies against which your generic must prove bioequivalence.

Sourcing the exact RLD requirements isn’t just a procurement task; it is a critical milestone that dictates the timeline, budget, and ultimate success of your entire clinical trial or bio study. Without a validated, strategic supply chain, generic drug development can quickly derail due to unexpected delays, expired batches, or fragmented logistics.

At Neunco, we specialize in removing the complexity from this process, providing seamless, global RLD and comparator sourcing solutions that keep your clinical trials moving forward On Time and In Full (OTIF).

The Complex Reality of RLD and Comparator Sourcing

For pharmaceutical developers, securing the necessary clinical trial supply requires navigating a labyrinth of global regulations, tight expiration windows, and strict temperature requirements. Sourcing teams frequently struggle with:

Geographic Restrictions: Needing specific product lots from exact country origins to satisfy local regulatory bodies (e.g., FDA or EMA).

Batch and Lot Continuity: Securing a single, massive batch or specific multi-batch lots to reduce variables in testing.

Shelf-Life Pressure: Obtaining products with long expiry dates to ensure they remain viable through the entirety of a protracted trial.

Logistical Fragility: Preventing temperature excursions that could ruin highly sensitive, high-value brand-name drugs during transit.

Because sourcing comparators demands substantial time, effort, capital, and an extensive global network, relying on transactional or unverified suppliers introduces immense risk to your drug development pipeline.

How Neunco Safeguards Your Clinical Supply Chain

Neunco is more than a supplier; we are a strategic sourcing partner. We have engineered our global network and infrastructure specifically to address the unique pain points of comparator and RLD sourcing.

1. Custom-Centric Global Sourcing

Every clinical trial has its own set of strict parameters. Neunco adapts to your exact blueprint by offering:

Sourcing from precise countries of origin.

One-to-many pack delivery.

Single or multi-batch lot procurement.

Guaranteed long expiry dates and specific batch numbers.

2. Unmatched Global Footprint and Compliance

Navigating international distribution requires a rock-solid regulatory framework. Neunco holds a Wholesale Distribution Authorization (WDA) license and operates a truly global supply chain. We actively source and deliver RLDs and comparators worldwide from key regions including the EU, USA, South East Asia, Canada, Australia, Japan, Korea, and Latin America.

3. State-of-the-Art, Certified Storage Facilities

Proper storage is non-negotiable for preserving the integrity of your clinical supplies over the trial life cycle. Neunco boasts verified storage locations with a combined capacity of 20,000+ pallet positions, featuring ambient, refrigerated, and frozen conditions. Our key facilities include:

An EU GDP-certified warehouse in the Netherlands to anchor our European operations.

A certified, licensed distribution center in New Jersey, USA, driving our North American supply.

Whether you need to store a single piece or hundreds of thousands of packs, our secure storage management mitigates inventory risk throughout the entire life cycle of your study.

4. Validated Cold Chain Logistics

A traceable, flawless supply chain is essential for risk reduction. Neunco utilizes temperature-controlled, specialized vehicles for precise last-mile distribution. For international movements, we collaborate exclusively with qualified partners to guarantee the integrity of cold chain and temperature-sensitive shipments from origin to site.

The Neunco Process: Transparency in Action

We believe that smooth project execution requires total visibility. Our committed project management team guides every order through a rigorous, four-step cycle, backed by a status tracking system that allows you to actively monitor your order:

Understanding: We deep-dive into your specific trial prerequisites and regulatory needs.

Scrutinizing: Our powerful research team evaluates every sourcing option available globally to uncover optimum results.

Assessing: We conduct meticulous risk assessments of various sourcing routes to narrow down the safest, most efficient path.

Proposing: We present data-driven, recommended sourcing strategies designed to optimize your cost management and trial timelines.

Accelerate Your Development with Neunco

Choosing the right clinical trial supplier can mean the difference between market leadership and costly, exhausting delays. By combining comprehensive global reach, rigid adherence to GDP standards, powerful research capabilities, and an uncompromising focus on customer experience, Neunco checks every box.

Let us handle the complexities of your RLD and comparator supply chain so your team can focus on what matters most: driving innovation and expanding access to quality treatments worldwide.

Ready to streamline your next clinical trial? Contact the expert team at Neunco today to discuss your sourcing strategy.

The pharmaceutical landscape is complex, competitive, and constantly evolving. For companies looking to expand their product portfolio, penetrate new markets, or maximize the return on their drug development investments, strategic licensing is the key.

At Neunco, we understand that licensing is more than just a transaction—it’s a partnership that defines your next stage of growth. Our structured Licensing Services are designed to elevate your pharmaceutical business by connecting you with the right global partners and providing a clear path to market.

Here is how Neunco turns licensing challenges into opportunities.

1. The Power of In-Licensing and Out-Licensing

Navigating the difficulties of developing and marketing generic medications requires selecting the best partners. Neunco’s expertise lies in meticulously bridging this gap.

In-Licensing: If you are an investor or a company seeking to expand your product line, we connect you with drug manufacturers ready to bring their innovations to market. We help you choose the right drug to invest in, ensuring a strong business match.

Out-Licensing: If you are a drug manufacturer ready with a new product, we connect you with verified investors and established commercialization companies to market your drug, ensuring a consistent revenue stream and helping your business grow efficiently.

Our dedicated team conducts thorough due diligence and provides all-round project management from the first step, ensuring constant communication, openness, and ongoing support for a successful deal. Our global network spans key regions, including the EU, USA, CIS, Southeast Asia, Africa, Latin America, and the Middle East, guaranteeing you access to the best partners worldwide.

2. Unlock a Faster Path to Market with Rapid Acquisition

In the pharmaceutical industry, the first-mover advantage is everything. Neunco offers a streamlined solution to accelerate your commercialization timeline: Rapid Acquisition.

By utilizing our global contacts and pre-analyzed database, you can acquire:

Ready-to-file or Approved Dossiers: Skip lengthy R&D and filing processes to gain immediate market access.

Technology and Dossiers ready for Bio Studies: Jumpstart your development with proven assets.

We specialize in delivering dossiers for rare therapeutic areas and complex regulations. Critically, all acquired dossiers are created to be in accordance with the regulatory requirements of target markets such as the USA, Europe, Canada, Australia, Japan, and Semi-Regulated Markets, ensuring your drug performs at its optimum potential wherever you launch.

3. Beyond the Deal: Integrated Strategic Partnerships

A successful licensing agreement often requires world-class support services. Neunco doesn't just finalize the license—we connect you to the necessary strategic partners to manage every aspect of your project:

CRO (Contract Research Organization): For hassle-free R&D and tech transfer solutions.

CMO (Contract Manufacturing Organization): To outsource your specific manufacturing requirements.

CDMO (Contract Development and Manufacturing Organization): For integrated solutions, taking your project from research all the way to commercialization.

Neunco serves as the vital link, connecting businesses looking to acquire contract services, product technologies, and dossiers with our verified out-licensing partners. This partnership guarantees a constant flow of business for our partners and comprehensive, customized solutions for you.

Ready to Take Your Licensing Game to the Next Level?

At Neunco, we drive innovation and promote research, manufacturing, and drug development at every stage. We help you make smart decisions, expand your reach, and achieve your growth goals.

Join forces with us to transform the market and find the perfect partner to achieve your goals.

Contact Neunco today to learn more about how our expert team can elevate your business.

The pharmaceutical industry is a dynamic landscape where speed, quality, and regulatory compliance are paramount. For pharma and biotech companies focused on discovery and R&D, scaling up production can be a complex and capital-intensive hurdle. This is where the Contract Manufacturing Organization (CMO) steps in as an indispensable partner.

At Neunco, we understand that a successful drug launch hinges on more than just a breakthrough molecule—it requires an iron-clad, resilient supply chain. Our value proposition is to bridge the gap, connecting you with the right CMO/CDMO partners to optimize your benefits and streamline your journey from clinic to commercialization.

🔬 What is a CMO in Pharma, and Why is it Critical?

A CMO is a third-party organization that provides comprehensive manufacturing services to pharmaceutical and biotech clients. This can range from early-stage development and clinical trial materials to full commercial production.

The Core Benefits of Partnering with a CMO:

Cost Efficiency & Reduced Capital Expenditure: Building and maintaining a state-of-the-art manufacturing facility is immensely expensive. Partnering with a CMO eliminates this upfront capital cost, allowing you to allocate resources to core competencies like R&D.

Specialized Expertise: CMOs often possess highly specialized technical expertise and state-of-the-art equipment (e.g., for complex injectables or large molecules) that a single pharma company may not have in-house.

Scalability and Flexibility: A key advantage is the ability to quickly scale production up or down in response to demand fluctuations, from small clinical batches to large commercial volumes.

Accelerated Time-to-Market: By outsourcing manufacturing, you can significantly compress timelines, bringing life-saving therapies to patients faster.

✅ Neunco’s Strategic Edge in CMO Selection

The market is flooded with CMOs, but finding the right one that aligns with your specific product needs, quality standards, and compliance requirements is a challenge. This is where Neunco excels.

We don't just find a manufacturer; we facilitate a strategic partnership.

Deep-Dive Vetting: We connect you with a global network of CMOs, CDMOs, and CROs, all rigorously vetted for their regulatory track record (e.g., cGMP compliance), technical capabilities, and capacity availability.

End-to-End Solutions: Beyond manufacturing, Neunco's expertise in Clinical Trial Supply, Comparator Drug sourcing, and Global Distribution ensures a seamless transition. A strong manufacturing partner is only half the equation; getting the product where it needs to go efficiently is the other.

Risk Mitigation: The ultimate responsibility for product quality lies with the contracting pharma company. We help mitigate this risk by connecting you with reliable partners, providing thorough consulting, and setting up the communication frameworks necessary for effective quality oversight and robust quality agreements.

💡 Beyond Manufacturing: A True Partnership

In today's competitive and regulated environment, the relationship between a pharma company and its CMO is less client-vendor and more a collaborative partnership.

Neunco helps foster a relationship built on:

Transparency: Ensuring clear and timely communication, especially regarding process deviations or supply chain issues.

Quality & Compliance: Focusing on CMOs with proven, robust Quality Management Systems (QMS) that adhere to international regulatory standards.

Shared Vision: Aligning the CMO's goals and capabilities with your product's lifecycle requirements, from API sourcing to final finished dose.

By leveraging Neunco’s network and expertise, pharmaceutical companies can secure the manufacturing muscle and global reach needed to succeed, allowing them to remain focused on innovation and patient care.

Developing new drugs, whether innovative or generic, relies heavily on a critical first step: securing the right pharmaceutical supplies for clinical trials and bio studies. This blog post explores the challenges and solutions in sourcing Comparator drugs and Reference Listed Drugs (RLDs), and how strategic partners like Neunco can streamline the process.

Comparator Sourcing for Clinical Trials

Comparator drugs are essential for pre-clinical and clinical trials, serving as the benchmark against which new drug candidates are measured. Sourcing these comparators requires substantial time, effort, money, and a robust global network.

Neunco's Customised Comparator Services: Neunco offers tailored services in sourcing and distributing Comparators globally. Their services ensure that clients have the right product for their studies, delivered On Time and In Full (OTIF). Key offerings include:

Sourcing from a specific country

One-to-many pack delivery

Single or multi-batch lots

Products with long expiry dates

Sourcing a specific batch number

Reference Listed Drug (RLD) Sourcing for Generic Drug Development

Reference Listed Drugs (RLDs) are the foundation for creating generic drugs. Strategic RLD sourcing is crucial for generic drug manufacturers to support development, increase accessibility, and ensure the availability of quality treatments worldwide.

Neunco facilitates exact RLD requirements using its global network of qualified sourcing experts and a validated, temperature-controlled logistics chain.

Flawless Supply Chain Management and Global Reach

A flawless supply chain is essential for the success of any clinical trial. Neunco manages the complexities of global distribution to ensure product integrity and timely delivery:

Certified Storage: They maintain state-of-the-art, certified storage spaces, including an EU GDP-certified warehouse in the Netherlands and a certified distribution center in New Jersey, USA. These facilities offer over 20,000 pallet positions in ambient, refrigerated, and frozen conditions.

Global Distribution: Neunco delivers Comparators and RLDs worldwide, sourcing from the EU, USA, South East Asia, Canada, Australia, Japan, Korea, and Latin America.

Logistics: They use temperature-controlled, specialised vehicles for last-mile and international cold chain shipments.

A Customer-Centric and Transparent Approach

Neunco follows a structured, customer-centric process to manage the entire sourcing cycle:

Understanding: Clearly defining the client's trial requirements.

Scrutinizing: Examining every available sourcing option for optimum results.

Assessing: Evaluating risks and sourcing routes to determine the best fit.

Proposing: Recommending a strategic sourcing plan for maximum benefit.

They ensure transparency through a status tracking system that allows clients to actively monitor their order throughout the process.

Why Choose Neunco?

By partnering with an experienced supplier like Neunco, sponsors gain flexibility, better risk identification, and streamlined Clinical Trial Supplies Management (CTSM). Their key strengths include:

Unmatched expertise and a powerful research team.

Detailed understanding of the market and proper cost management.

Regulatory compliance and global reach.

Choosing the right clinical trial supplier—one with reliability, expertise, and global reach—is paramount for smooth and efficient project progression.

 The journey of bringing a generic drug to market is complex, demanding precision, compliance, and a reliable supply chain. At the heart of this process is the Reference Listed Drug (RLD)—the innovator product used as a standard for bioequivalence studies and Abbreviated New Drug Application (ANDA) submissions.

For pharmaceutical companies operating in or targeting the vast Indian and global generic markets, securing authentic, traceable, and compliant RLDs can be a significant bottleneck. This is where Neunco Pharmaceutical India LLP steps in as your strategic partner.

The Critical Role of RLD Sourcing

The RLD is not just a sample; it is the benchmark against which a generic version must prove its therapeutic equivalence. Challenges in RLD sourcing often include:

Availability: Finding specific batches, strengths, or packaging formats.

Traceability: Ensuring the drug is authentic and has a clear chain of custody.

Compliance: Meeting the stringent documentation and regulatory requirements of global agencies (like the FDA, EMA, or CDSCO).

Logistics: Managing temperature-sensitive products and complex cross-border shipments.

Why Choose Neunco for Your RLD Needs in India?

Neunco is committed to streamlining your drug development pipeline. Our presence and operational strength in India, combined with a robust global network, make us an exceptional choice for your RLD and Comparator Drug sourcing needs.

1. Strategic Sourcing, Global Reach, Local Presence

Our team leverages a global network to source RLDs from various primary markets (USA, EU, etc.) to meet specific regulatory requirements. With a dedicated office in Ahmedabad, Gujarat, India, Neunco Pharmaceutical India LLP ensures local expertise in navigating the country's unique import and distribution landscape, delivering directly to your research facility.

2. End-to-End Compliance and Quality Assurance

Generic development hinges on impeccable documentation. We provide RLDs accompanied by comprehensive, compliance-ready documentation, including:

Certificates of Analysis (CoA)

Batch Records

Import/Export Licensing Support

Our rigorous quality assurance process ensures every product maintains its integrity from the point of origin until it reaches your lab for those crucial Bioequivalence (BA/BE) studies.

3. Solutions Tailored for Indian Pharma

The Indian pharmaceutical industry is a global leader in generics. We understand the high-stakes environment and the need for speed and cost-efficiency. Neunco offers solutions designed to save your project heavy costs and critical time by:

Providing a proposed delivery plan with an optimized availability schedule.

Strategically sourcing both the RLD (Reference Listed Drug) and Comparator Drugs for clinical trials.

Partnership for Progress

At Neunco, we view ourselves as more than just a supplier; we are consultants dedicated to promoting constructive change in healthcare. By partnering with us for your RLD sourcing, you gain a strategic advantage: an efficient supply chain that underpins the foundation of your generic drug development process.

Ready to streamline your Reference Listed Drug sourcing? Contact Neunco Pharmaceutical today to discover a strategic and compliant path forward for your generic drug development projects.

 In today's fast-paced pharmaceutical industry, speed-to-market and regulatory compliance are non-negotiable. Whether you are a small biotech startup or a large established pharmaceutical firm, efficiently managing your product's lifecycle—from Active Pharmaceutical Ingredient (API) development to finished drug product (FDF) manufacturing—is essential for success.

This is where Pharmaceutical Contract Manufacturing (PCM) becomes a strategic necessity. By outsourcing specialized production tasks to a third-party manufacturer, companies can save on capital expenditures, focus on R&D, and tap into global expertise.

But simply choosing a contract manufacturer is not enough. You need the right partner. This is the pivotal role that Neunco plays in the ecosystem.

Neunco: Your Strategic Partner in Pharma Contract Services

Neunco is not a manufacturer itself; it is a dedicated pharmaceutical consultancy acting as the essential bridge between drug developers and the world’s best contract manufacturers. Our mission is to transform the complex, high-stakes process of outsourcing into a smooth, streamlined operation.

We recognize that every drug molecule, market, and regulatory requirement is unique. Our approach is built on a foundation of rigorous due diligence and a deep understanding of your specific needs.

The Neunco Difference: A Vetted Global Network

We leverage a vast database and wide industry experience to connect you with contract manufacturers who maintain two critical standards:

International Compliance: Our partners are vetted to ensure they adhere to the highest global regulatory standards, giving you peace of mind regarding quality and market access.

Flexibility and Reliability: We match you with partners who are flexible in their dealings and can scale production to meet your market demands, from small-scale clinical batches to large-volume commercial production.

Key Services and Areas of Expertise

Neunco's contract manufacturing services encompass critical stages of the pharmaceutical supply chain:

Active Pharmaceutical Ingredient (API) Contract Manufacturing: The API is the core of any drug. We help you connect with specialized partners who can handle the complex development and production of your active ingredient, ensuring maximum purity and yield.

Finished Drug Product (FDP) Manufacturing: From tablets and capsules to injectables and specialized formulations, we source contract development and manufacturing organizations (CDMOs) and contract manufacturing organizations (CMOs) that can deliver high-quality, finished products.

Full Contract Services (CRO, CMO, CDMO): Beyond manufacturing, our team is adept at connecting you with the right Contract Research Organizations (CROs) for clinical trials and full CDMOs that can handle the entire development process from concept to commercialization.

Benefits of Partnering with Neunco

 In the complex and heavily regulated world of pharmaceuticals, the journey from lab bench to patient is fraught with logistical and operational challenges. A critical decision for any pharmaceutical company is Contract Manufacturing—the process of outsourcing production to a specialized third-party, a CMO or CDMO.

But finding the right manufacturing partner isn't a simple task. It requires deep industry knowledge, a global network, and an absolute commitment to quality and compliance. This is where Neunco steps in. We act as your expert consultant, turning a complex outsourcing challenge into a streamlined, strategic business advantage.

Navigating the CMO/CDMO Maze with Neunco

The global Contract Manufacturing Organization (CMO) and Contract Development and Manufacturing Organization (CDMO) landscape is vast. Simply searching for a manufacturer can lead to suboptimal partnerships that result in delays, quality issues, or unnecessary costs.

Neunco's service is built on three core pillars that ensure a successful outsourcing strategy:

1. Strategic Partner Vetting and Connection

We don't just provide a list of names; we connect you with the right partner. Our team is dedicated to a rigorous selection process, ensuring the CMO/CDMO meets your specific product requirements—whether it's for Active Pharmaceutical Ingredients (APIs), Finished Dosage Forms (FDFs), or specialized drug types. We leverage our extensive, global network of verified contract service providers to find the perfect fit, saving you countless hours of due diligence.

2. Compliance and Quality Assurance

Compliance is non-negotiable in pharmaceuticals. Neunco prioritizes quality, partnering with manufacturers who uphold international standards. Beyond the production site, we ensure supply chain compliance, leveraging our own established global logistics footprint, including EU-GDP-certified warehouse storage in the Netherlands and a distribution center in the USA. This oversight minimizes risk and ensures the integrity of your product from manufacturing through to final distribution.

3. Maximizing Efficiency and Cost-Effectiveness

Every day a drug is delayed is a day of lost revenue. Neunco's expertise in strategic sourcing and supply chain management is designed to accelerate your product's time-to-market. By optimizing the selection and onboarding process for your contract manufacturer, we help you achieve greater efficiency, streamline logistics, and ultimately realize significant cost savings.

More Than Manufacturing: The Neunco Difference

Neunco’s consultation services are comprehensive, covering the entire pharmaceutical product lifecycle. Our expertise extends beyond manufacturing to include crucial related services, making us a holistic partner:

Clinical Trial Supply: Ensuring the right comparators and Reference Listed Drugs (RLDs) are sourced and delivered on time for your clinical studies.

Global Distribution: Utilizing our strategically located distribution channels across the EU, USA, and India to facilitate your global market expansion.

Licensing Services: Providing advisory on in-licensing and out-licensing to strengthen your intellectual property and market positioning.

When you partner with Neunco, you're not just hiring a consultant; you're gaining an extension of your team—a seasoned expert dedicated to securing the highest quality, most efficient, and most compliant contract manufacturing solution for your pharmaceutical success.

Ready to find your ideal manufacturing partner and accelerate your market strategy?

 The development of affordable, high-quality generic drugs is a critical component of global healthcare. At the heart of this process lies the Reference Listed Drug (RLD)—the gold standard approved by regulatory bodies like the FDA and EMA. For generic manufacturers, reliably sourcing the exact RLD is not just a procurement task; it is the essential first step toward demonstrating bioequivalence and gaining regulatory approval.

For the vibrant and rapidly growing generic pharmaceutical industry in India, securing authentic, traceable, and timely RLD supplies is paramount. This is where a dedicated, globally-connected partner like Neunco steps in. With a strong presence in India, coupled with an international logistics network, Neunco is streamlining RLD sourcing to power the next wave of generic drug innovation.

The RLD Sourcing Challenge in India

Indian pharmaceutical companies often face complex challenges when sourcing RLDs:

Global Sourcing Complexity: RLDs often need to be sourced from their original markets (EU, USA) to meet specific regulatory requirements for the Abbreviated New Drug Application (ANDA). This requires navigating international logistics, customs, and global pharmaceutical regulations.

Maintaining Product Integrity: RLDs, especially specialty and biologic drugs, require strict cold chain and temperature-controlled storage and transport. Any lapse can compromise the integrity of the reference standard.

Timeliness and Traceability: Delays in RLD delivery can significantly impact the timeline for clinical trials and bioequivalence studies, slowing down time-to-market for generics. End-to-end traceability is also non-negotiable for compliance.

Neunco’s Solution: A Global Network with an Indian Footprint

Neunco addresses these challenges by offering a comprehensive, customer-centric solution, anchored by its global infrastructure and local presence in India (Ahmedabad).

1. Global Reach, Local Expertise

Neunco operates distribution channels in key pharmaceutical hubs, including the EU, USA, and India (Ahmedabad). This unique structure provides generic developers in India with several key advantages:

Direct Access to International RLDs: Leveraging its international hubs (like the EU-GDP-certified warehouse in the Netherlands and a facility in the USA), Neunco ensures direct and efficient procurement of RLDs that meet stringent global regulatory standards.

Streamlined Imports: The Neunco India office acts as the local point of contact, expertly managing the complex documentation, customs clearances, and regulatory processes necessary for the seamless import of RLDs into India.

2. Guaranteed Supply Chain Integrity

For bioequivalence studies, the integrity of the RLD is everything. Neunco’s commitment to quality ensures the reference standard remains valid from the point of origin to your lab door:

Validated Logistics Chain: We utilize a validated logistics chain and qualified partners for all shipments, specializing in cold chain and temperature-controlled transportation for sensitive products.

Certified Storage: Our state-of-the-art certified storage spaces maintain the optimal conditions for RLDs throughout the entire life cycle of your study, ensuring product stability and compliance.

3. Customer-Centric and Transparent Service

At Neunco, we understand that every generic development project has unique requirements for batch size, expiry, and documentation.

“On Time and In Full” (OTIF) Commitment: Our global network and efficient supply chain management are optimized to facilitate exact RLD requirements delivered On Time and In Full (OTIF).

Real-Time Status Tracking: We believe in transparency. Our status tracking system allows clients to actively monitor their order from procurement to final delivery, providing peace of mind and better project planning.

Experienced Sourcing Experts: Our team is highly knowledgeable in the sourcing and distribution of RLDs, providing tailored services that meet the diverse and dynamic needs of the Indian pharmaceutical market.

Conclusion: Partnering for Generic Success

India’s position as the “pharmacy of the world” depends on the efficiency and reliability of its generic drug development pipeline. By choosing a trusted Reference Listed Drug supplier like Neunco, generic manufacturers secure more than just a drug; they secure a strategic partnership built on global compliance, flawless logistics, and a shared commitment to bringing quality, affordable medicines to patients worldwide.

Ready to streamline your bioequivalence studies?

Contact Neunco today to discuss your Reference Listed Drug (RLD) sourcing needs.

In the competitive world of pharmaceuticals, bringing a breakthrough formulation from concept to patient is a complex journey. For a company focused on innovation, like Neunco, every strategic decision must maximize efficiency, quality, and speed-to-market. That is why Contract Manufacturing of Formulations is not just an outsourcing option—it is a critical and transformative business strategy.

What is Contract Manufacturing of Formulations?

Pharmaceutical Contract Manufacturing is the practice of outsourcing the production of a finished dosage form (like tablets, capsules, injectables, or oral liquids) to a specialized third-party organization, known as a Contract Manufacturing Organization (CMO) or a Contract Development and Manufacturing Organization (CDMO).

For Neunco, this means we provide the proprietary formula and specifications, and our trusted manufacturing partner handles the intricate process of large-scale production, adhering to the strictest global regulatory standards.

The Strategic Edge for Neunco

Choosing to partner with a world-class CMO is a strategic move that amplifies Neunco’s core strengths and mitigates operational challenges.

1. Focus on Core Competencies: Research and Development

Neunco’s true value lies in our deep-seated commitment to innovative research and the development of next-generation drug formulations. Building and maintaining a global-scale manufacturing infrastructure demands massive capital investment, highly specialized personnel, and significant managerial focus—resources that are better allocated to our R&D pipeline.

Our Focus: Accelerating new drug discovery, optimizing clinical trial supply, and expanding our intellectual property.

CMO's Focus: Ensuring seamless, large-scale, high-quality production of the approved formulation.

By delegating production to an expert partner, we can concentrate our capital and intellectual power on what we do best: Innovation.

2. Accelerate Time-to-Market and Enhance Scalability

In the race to bring life-saving medicines to patients, speed is paramount. Our contract manufacturing partners already possess validated, cGMP-compliant facilities, established supply chains, and seasoned production teams.

Speed: We bypass the years it would take to design, construct, validate, and license a new manufacturing plant. Our products move faster from final development stage to commercial launch.

Flexibility & Scalability: Market demand can fluctuate. A contract manufacturer offers the agility to quickly scale production up for a massive commercial launch, or scale down to manage evolving market needs, all without incurring the high fixed costs and risks of underutilized in-house capacity.

3. Access to Specialized Expertise and Cutting-Edge Technology

Formulation manufacturing is a field of constant technological evolution. Our chosen CMOs invest continuously in state-of-the-art equipment and specialized processes that may be too niche or too expensive for Neunco to replicate in-house.

Advanced Technologies: We gain immediate access to complex capabilities such as sterile manufacturing, high-containment suites for potent compounds, and specialized solid dosage forms.

Regulatory Mastery: Reputable CMOs are experts in navigating complex global regulatory environments (FDA, EMA, WHO-GMP, etc.). This ensures that Neunco's products are manufactured in full compliance, minimizing regulatory risks and facilitating international market access.

4. Transform Fixed Costs to Variable Costs

The financial model of contract manufacturing is inherently efficient. Instead of bearing the immense fixed costs associated with plant depreciation, utility bills, maintenance, and large in-house teams, Neunco pays for manufacturing services as a variable cost based on production volume. This financial flexibility strengthens our balance sheet and allows us to deploy capital more strategically across our development projects.

The Neunco Approach to Partner Selection: Quality First

The success of a contract manufacturing strategy hinges on selecting the right partner. For Neunco, our selection process is rigorous, focusing on unwavering commitment to quality. We seek partners who demonstrate:

Impeccable Regulatory Track Record: Proven history of adherence to global cGMP standards and successful audits.

Technical Fit: Expertise specifically in the dosage form (tablet, liquid, injectable, etc.) required by our unique formulation.

Transparency and Communication: A commitment to open book policies, clear batch documentation, and proactive project management.

A Shared Quality Culture: Our partner's commitment to quality assurance must align perfectly with Neunco’s own high standards.

Conclusion: Manufacturing as a Collaborative Art

For Neunco, contract manufacturing is more than a transaction; it is a strategic collaboration. It allows our brightest scientists to focus on creating the next generation of medicines, while our world-class manufacturing partners focus on bringing those medicines to life, safely and efficiently.

This model allows Neunco to remain nimble, competitive, and focused on our ultimate mission: Delivering innovative, high-quality formulations to patients around the world, faster and more reliably than ever before.

 The journey of bringing a pharmaceutical product to market is complex, capital-intensive, and highly regulated. For many pharma companies, outsourcing production to a Contract Manufacturing Organization (CMO) is the most strategic path to efficiency, scalability, and global compliance.

But how do you find the perfect CMO—one that aligns with your specific drug requirements, international quality standards, and budget?

This is where Neunco Pharmaceutical steps in. We don't just provide a service; we provide a strategic partnership dedicated to connecting you with the world-class Contract Manufacturing, Contract Research (CRO), and Contract Development and Manufacturing (CDMO) partners that fit your product's needs best.

Neunco: Your Navigator in the Global CMO Landscape

Neunco acts as your dedicated pharmaceutical consultancy, specializing in strategic sourcing and contract services across the product lifecycle. Our core expertise lies in meticulously researching, vetting, and connecting you with the ideal manufacturing partners globally.

Here is why partnering with Neunco is the smart move for your manufacturing strategy:

1. Curated Network of Vetted Global Partners

The pharmaceutical manufacturing landscape is vast. Navigating it alone can be time-consuming and fraught with risk. Neunco has cultivated a robust, pre-analysed database and a wide network of third-party pharma manufacturers who maintain the highest international standards.

International Standards: We partner with CMOs who adhere to strict global regulations, ensuring your product is manufactured to the quality required for markets like the EU, USA, and beyond.

Flexibility and Customization: We understand that every drug and company is unique. We look beyond basic capacity to find partners who are flexible in their dealings and can tailor their services (from Active Pharmaceutical Ingredient (API) manufacturing to Finished Dosage Formulation (FDF)) to your specific requirements.

2. Strategic Sourcing for API and FDF Manufacturing

The core of any pharmaceutical product is the Active Pharmaceutical Ingredient (API). Sourcing or manufacturing your API cost-effectively and reliably is critical. Similarly, the final dosage form (FDF) requires specialized technology and expertise.

Neunco offers Strategic Sourcing solutions for both API and FDF to streamline your supply chain management. Our deep industry experience allows us to connect you with contract manufacturers who specialize in the exact process your drug requires, ensuring both quality and a competitive price.

3. Compliance-Driven Vetting and Research

In the pharmaceutical world, compliance is non-negotiable. Our team is adept at conducting thorough due diligence. Before presenting any potential partner, we perform extensive research to ensure the CMO not only meets your technical specifications but also aligns with all relevant market compliance requirements.

This dedication to research and vetting means you get:

Risk Mitigation: We significantly reduce the risk of non-compliance, quality issues, or supply chain disruptions.

Market-Ready Solutions: We ensure the chosen CMO can manufacture your product in a way that aligns with the regulatory requirements of your target markets.

4. Beyond Manufacturing: A Full Spectrum of Contract Services

Neunco’s Contract Services extend beyond just finding a CMO. We connect you with a network of partners across the drug development lifecycle, offering comprehensive and customised solutions:

CRO (Contract Research Organization) Partners: For hassle-free Research & Development and technology transfer solutions.

CDMO (Contract Development and Manufacturing Organization) Partners: For integrated solutions that cover everything from research to the commercialization of your project.

Seamless Process, Smooth Transition

When you choose Neunco, you choose a simple, well-researched process:

Needs Assessment: We thoroughly understand your drug, your target market, and your exact manufacturing requirements.

Partner Identification: We leverage our global database and network to identify the most suitable, internationally compliant CRO, CMO, or CDMO partners.

Introduction and Support: We approach you with our findings, complete with all the necessary research, facilitating a smooth introduction and ensuring constant communication and openness throughout the negotiation process.

The goal is a seamless partnership that saves you significant time and heavy operational costs.

Ready to Optimize Your Pharmaceutical Supply Chain?

Don't let the complexity of contract manufacturing slow down your product's path to market.

At Neunco, our commitment is to promote constructive change for a better future by providing you with the finest healthcare solutions. Whether you need a partner for Active Pharmaceutical Ingredient (API) contract manufacturing or a full-service CDMO, our team is dedicated to connecting you with the right fit to optimize your benefits.

Contact Neunco today to discuss your contract manufacturing needs and unlock a faster, more efficient pathway to commercialization.

 The Active Pharmaceutical Ingredient (API) is the core of any drug—the component that produces the intended therapeutic effect. For pharmaceutical companies, securing a reliable, high-quality, and compliant API supply chain is a process fraught with complexity. This is where Neunco's specialized expertise in API contract manufacturing becomes an invaluable strategic asset.

Neunco, a prominent name in pharmaceutical consultancy, is dedicated to simplifying this intricate process, connecting pharmaceutical companies with the ideal partners to manage the development and production of their Active Pharmaceutical Ingredients.

The Neunco Difference in API Contract Manufacturing

Neunco's approach is not just about connecting parties; it is a comprehensive, consultative service built on market knowledge, due diligence, and a commitment to regulatory excellence.

1. Strategic Partner Selection for Ultimate Quality

API contract manufacturing involves outsourcing the overall development and production of the API to a third-party manufacturer (a CMO or CDMO). The quality of this partner is paramount.

Vast Network of Vetted Manufacturers: Neunco leverages its extensive database and deep industry experience to partner with well-known third-party manufacturers. These partners are meticulously selected based on their adherence to international standards and their flexible, client-focused business dealings.

Compliance-First Approach: Keeping global market compliance requirements (such as GMP—Good Manufacturing Practices) in mind, Neunco introduces pharma companies to manufacturers who will ensure that the API's efficacy and quality are maintained without compromise.

2. Tailored Solutions, Not Just Referrals

Every drug and every pharmaceutical company has unique requirements. Neunco’s consultative model ensures the contract manufacturing solution is perfectly aligned with the client's needs.

In-Depth Market & Drug Analysis: The Neunco team is adept at conducting thorough research, checking which potential contract manufacturers "tick all the boxes" for a specific project. They first take the time to deeply understand your drug, the target market, and the technical specifications required for its production.

A Smoother Path Forward: By providing clients with all their research and findings, Neunco enables a smooth process from initial concept to commercial-scale production. This deep-dive vetting and matchmaking eliminates guesswork and significantly mitigates risks.

Why Pharmaceutical Companies Choose Neunco

Partnering with Neunco for API contract manufacturing provides significant strategic advantages that go far beyond a simple transaction:

Expert Access & Cost Avoidance: API manufacturing requires substantial investment in infrastructure, specialized equipment, and scientific expertise. By utilizing Neunco’s services, companies can immediately tap into this specialized expertise and world-class manufacturing capacity, avoiding the immense capital and operational costs of setting up and maintaining their own facilities.

Focus on Core Competencies: Delegating API production to an expert partner frees up the client company to enhance its core competencies, which often include crucial areas like research, clinical development, marketing, and distribution.

Rapid Market Entry and Risk Mitigation: Neunco’s partners are equipped to efficiently navigate complex regulatory prospects and scale up production as required. This flexible, fast-paced nature helps pharmaceutical products get to market faster, while robust supply chain strategies and contingency plans mitigate risks related to supply and production stability.

Neunco: Your Partner Across the Product Lifecycle

Active Pharmaceutical Ingredient contract manufacturing is a key component of Neunco's comprehensive suite of services, which span the entire pharmaceutical product lifecycle. In addition to contract services (CMO, CDMO, CRAMS), Neunco offers:

Strategic Sourcing: Sourcing of both APIs and Finished Drug Products (FDFs).

Clinical Trial Supply: Sourcing of Comparator Drugs and Reference Listed Drugs (RLD).

Global Distribution: A strong presence with distribution centers in strategic locations like the EU (Netherlands), USA (New Jersey), and India.

In Conclusion:

Neunco acts as the essential bridge between innovative pharmaceutical ideas and compliant, high-quality manufacturing reality. Our core value lies in using our wide experience and robust global network to connect you with the right pharmaceutical partner—one that upholds international quality standards, ensures regulatory compliance, and is committed to your product's success.

Ready to find the ideal contract manufacturer for your Active Pharmaceutical Ingredient?

Connect with the professionals at Neunco today to learn more about how we proficiently manage API contract manufacturing to bring your life-saving products to the world.

The pharmaceutical landscape is in a constant state of evolution. As new technologies emerge and regulatory demands become more stringent, the logistics of clinical trials have grown increasingly complex. At Neunco, we don't just keep up with these changes—we help our clients stay ahead of them. Our mission is to streamline your pharmaceutical product lifecycle, and a critical part of that is ensuring a seamless and compliant clinical trial supply chain.

The future of clinical trial supplies is defined by a few key trends:

1. The Rise of Decentralized and Patient-Centric Trials The shift toward decentralized clinical trials (DCTs) is revolutionizing patient recruitment and retention. By bringing the trial directly to the patient, we reduce the burden on participants and improve accessibility. This model, however, places new demands on the supply chain, requiring reliable and secure direct-to-patient (DTP) solutions. At Neunco, we have the expertise to manage these complex logistics, ensuring investigational medicinal products (IMPs) are delivered safely and on time to patients' homes, maintaining the integrity of the trial.

2. Embracing Digital Transformation The pharmaceutical supply chain is no longer just about physical logistics; it's about data and intelligence. Technologies like blockchain, AI-driven forecasting, and real-time inventory tracking are transforming the industry. These innovations enhance transparency, reduce waste, and provide greater visibility into the entire supply chain. Neunco leverages these advanced digital tools to optimize inventory levels, prevent shortages, and provide our clients with a data-driven approach to clinical supply management.

3. The Move to Personalized Medicine and Just-in-Time Solutions Precision medicine is here, and it's changing how drugs are developed and delivered. The days of one-size-fits-all, bulk manufacturing are fading. With the rise of personalized therapies and small-batch manufacturing, the need for flexible, just-in-time (JIT) clinical supply solutions is paramount. This approach minimizes drug wastage and optimizes costs, ensuring that investigational products are produced and shipped only when and where they are needed. Our tailored solutions are designed to support these low-volume, high-value clinical trials, ensuring the right treatment reaches the right patient at the right time.

4. Sustainability and Compliance In an increasingly environmentally conscious world, sustainable practices are no longer an option—they are a necessity. From eco-friendly packaging materials to optimized, temperature-controlled logistics, we are committed to minimizing the environmental impact of clinical trial supplies. Furthermore, with our EU-GDP and USA-WDA certified warehouses and a global network of partners, we ensure that every step of the supply chain is fully compliant with the highest regulatory standards. Our dedication to quality and integrity guarantees the safety and efficacy of your clinical trial materials.

Neunco: Your Partner in Clinical Trial Excellence

At Neunco, we provide end-to-end solutions for your clinical trial needs. Our services are comprehensive, including:

Comparator and Reference Listed Drug (RLD) Sourcing: Our strategic sourcing solutions save you significant time and cost.

Clinical Trial Packaging and Labeling: Ensuring your IMPs are packaged and labeled in compliance with all global regulations.

Global Distribution: A robust network spanning the EU, USA, and India to ensure seamless worldwide delivery.

Strategic Sourcing and Consulting: Guiding you to the right partners to optimize your entire product lifecycle.

The journey from a novel molecule to a life-saving drug is complex and challenging. Don't let your supply chain be a weak link. Partner with Neunco to leverage cutting-edge innovations and ensure seamless, efficient, and compliant supply chain management for your clinical trials.

Ready to transform your clinical trial logistics? Contact us today to learn how we can support your next study.

 In the fast-paced world of pharmaceutical development, speed and accuracy are paramount. For generic drug manufacturers, contract research organizations (CROs), and bioequivalence testing facilities in India, one of the most critical steps is sourcing authentic Reference Listed Drugs (RLDs). These are the original brand-name medications that serve as the gold standard for comparison, ensuring that new generic versions are safe, effective, and compliant with regulatory standards

At Neunco, we understand that RLD sourcing is not just a logistical challenge—it's the cornerstone of a successful project. Delays, inaccurate documentation, or compromised product quality can derail a project, leading to significant financial losses and setbacks. This is where Neunco’s expertise in RLD sourcing in India truly makes a difference.

The Challenges of Sourcing RLDs in India

Navigating the complexities of the Indian pharmaceutical market requires a deep understanding of local regulations, a robust network of suppliers, and a commitment to quality. Without a reliable partner, organizations face a number of hurdles:

Ensuring Authenticity: The market is flooded with various suppliers, and ensuring the authenticity and quality of RLDs is a constant concern.

Regulatory Compliance: Understanding and adhering to intricate import regulations, documentation requirements, and storage conditions is crucial.

Timely Procurement: Delays in obtaining RLDs can halt research and development, impacting project timelines and time-to-market.

Cost Management: Balancing the need for high-quality RLDs with budget constraints is an ongoing challenge.

Neunco: Your Trusted Partner in RLD Sourcing

Neunco is committed to providing a seamless and efficient RLD sourcing experience in India. We have built a reputation on our ability to navigate these challenges with precision and expertise, ensuring our clients receive the authentic reference standards they need, when they need them.

Why Choose Neunco for Your RLD Sourcing Needs?

Global Network, Local Expertise: While we have a global presence with offices in the USA, Europe, and India, our dedicated Indian team possesses in-depth knowledge of the local landscape. We have a validated network of suppliers and partners, ensuring the authenticity and traceability of every product.

Regulatory Mastery: Our team is well-versed in the complex import and export regulations in India. We handle all the necessary documentation, ensuring a smooth and compliant procurement process from start to finish.

Seamless Supply Chain Management: We understand the urgency of your R&D projects. Our streamlined processes and temperature-controlled logistics ensure efficient and timely delivery of RLDs, minimizing project delays and maximizing efficiency.

Customer-Centric Approach: We don't believe in a one-size-fits-all solution. We work closely with our clients to understand their specific needs and provide tailored sourcing strategies that fit their project requirements and budget.

Transparency and Trust: With our status tracking system, you can actively monitor your order throughout the entire cycle, giving you peace of mind and complete transparency.

By partnering with Neunco for your RLD sourcing in India, you can streamline your supply chain, reduce procurement complexities, and focus on your core research and development activities. We are more than just a supplier; we are your reliable partner in ensuring the success of your pharmaceutical endeavors.

To learn more about how Neunco can assist with your RLD sourcing requirements, contact us today.